MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

Data as of Oct 20
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

MabVax Therapeutics Holdings, Inc. is a clinical stage oncology drug development company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.

Contact Information

MabVax Therapeutics Holdings, Inc.
11588 Sorrento Valley Road
San Diego California 92121
P:(858) 259-9405
Investor Relations:



Other institutional7.07%
Mutual fund holders0.12%
Individual stakeholders--

Top Executives

John David HansenPresident, Chief Executive Officer & Director
Gregory P. HansonChief Financial Officer
Philip O. LivingstonDirector & Chief Science Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.